Stock Evaluator: Myomo, Inc. (MYO)

Myomo, Inc. MYO

$0.99 -0.01 -0.92%
July 31, 2026 11:14:47 AM EST November 10, 2021 Volume: 130,609
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD AMEX | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Commentary & Analysis


Financial Summary

Share Statistics MYO Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $38.6 $334.8 14%
Shares Out (Mil) 38.6 41.7 42%
Institutional Ownership 77.1% 77.3% 47%
Float (Mil) 26.8 34.7 34%
Beta 1.46 0.86 81%
Avg Daily Volume (000s) 333 266 53%
Price Change
(52-week)
(49.5%) 60.7% 16%
Growth MYO Industry
Median
Percentile
(All Stocks)
Sales (5yr) 40.0% 11.8% 93%
Net Income (5yr) (6.1%) (5.8%) 33%
EPS (5yr) 36.7% 10.7% 86
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (16.0%) (16.1%) 45%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS ($0.100) ($0.317) ($0.253)
Month Ago EPS ($0.100) ($0.317) ($0.253)
# Rev Up 0 1 1
# Rev Down 1 0 0
Three Months Ago EPS ($0.093) ($0.338) ($0.263)
Year/Year Chg 28.2% (14.8%) (100.0%)
Financials MYO Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $41 $152 18%
Net Income (TTM) (Mil) ($15) ($11) 26%
EPS (TTM) ($0.392) ($0.500) 29%
Operating Cash Flow (TTM) (Mil) ($14) ($2) 17%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $18 $22 32%
Enterprise Value (Q1) (Mil) $46 $304 16%
Valuation MYO Industry
Median
Percentile
(All Stocks)
P/B 4.35 2.88 75%
P/E na 30.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios MYO Industry
Median
Percentile
(All Stocks)
Gross Margin 66.0% 59.1% 78%
Net Margin (36.7%) (7.7%) 13%
ROA (39.0%) (13.7%) 14%
ROE (98.5%) (15.9%) 10%
Liabilities to Assets 75.5% 44.9% 71%
F-Score 3 4 19%

Myomo, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors